Kate Therapeutics
Fae' Sedighi, Ph.D. is a Scientist II at Kate Therapeutics with experience in protein biochemistry, biophysical chemistry, and bioanalytical techniques. Previously worked at Codexis, Inc. as an AAV Vector Scientist and Analytical Development Scientist. Graduated with a Ph.D. in Protein biochemistry/ Biophysical chemistry/ Bioanalytical techniques from West Virginia University.
Kate Therapeutics
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.